Fgf10overexpression enhances the formation of tissue-engineered small intestine
Authors:
- Yasuhiro TorashimaYTYasuhiro Torashima
- Daniel E. LevinDLDaniel E. Levin
- Erik R. BarthelEBErik R. Barthel
- Allison L. SpeerASAllison L. Speer
- Frédéric G. SalaFSFrédéric G. Sala
- Xiaogang HouXHXiaogang Hou
- Tracy C. GrikscheitTGTracy C. Grikscheit
- 7 March 2013
- journal article
- research article
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 10 (2) , 132-139
Abstract
Short bowel syndrome (SBS) is a morbid and mortal condition characterized in most patients by insufficient intestinal surface area. Current management strategies are inadequate, but tissue-engineered small intestine (TESI) offers a potential therapy. A barrier to translation of TESI is the generation of scalable mucosal surface area to significantly increase nutritional absorption. Fibroblast growth factor 10 (Fgf10) is a critical growth factor essential for the development of the gastrointestinal tract. We hypothesized that overexpression of Fgf10 would improve the generation of TESI. Organoid units, the multicellular donor tissue that forms TESI, were derived from Rosa26rtTA/+, tet(o)Fgf10/– or Fgf10Mlc-nlacZ-v24 (hereafter called Fgf10lacZ ) mice. These were implanted into the omentum of NOD/SCID γ-chain-deficient mice and induced with doxycycline in the case of tet(o)Fgf10/–. Resulting TESI were explanted at 4 weeks and studied by histology, quantitative RT–PCR and immunofluorescence. Four weeks after implantation, Fgf10 overexpressing TESI was larger and weighed more than the control tissues. Within the mucosa, the villus height was significantly longer and crypts contained a greater percentage of proliferating epithelial cells. A fully differentiated intestinal epithelium with enterocytes, goblet cells, enteroendocrine cells and Paneth cells was identified in the Fgf10-overexpressing TESI, comparable to native small intestine. β-Galactosidase expression was found in both the epithelium and the mesenchyme of the TESI derived from the Fgf10LacZ duodenum. However, this was not the case with TESI generated from jejunum and ileum. We conclude that Fgf10 enhances the formation of TESI. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
Funding Information
- California Institute for Regenerative Medicine (RN2-00946-1, TG2-01168)
This publication has 29 references indexed in Scilit:
- A Multicellular Approach Forms a Significant Amount of Tissue-Engineered Small Intestine in the MouseTissue Engineering Part A, 2011
- Growth factors: possible roles for clinical management of the short bowel syndromeSeminars in Pediatric Surgery, 2010
- Relationship between biopsy-proven parenteralnutrition-associated liver fibrosis and biochemical cholestasis in children with short bowel syndromeJournal of Pediatric Surgery, 2010
- Induction of fibroblast growth factor 10 (FGF10) in the ileal crypt epithelium after massive small bowel resection suggests a role for FGF10 in gut adaptationDevelopmental Dynamics, 2009
- Fibroblast growth factor 10 is required for survival and proliferation but not differentiation of intestinal epithelial progenitor cells during murine colon developmentDevelopmental Biology, 2006
- Intestinal and Multivisceral Transplantation in ChildrenAnnals of Surgery, 2006
- Stomach Development Is Dependent on Fibroblast Growth Factor 10/Fibroblast Growth Factor Receptor 2b–Mediated SignalingGastroenterology, 2006
- The fibroblast growth factor pathway serves a regulatory role in proliferation and apoptosis in the pathogenesis of intestinal atresiaJournal of Pediatric Surgery, 2006
- Fibroblast growth factor-10 serves a regulatory role in duodenal developmentJournal of Pediatric Surgery, 2005
- FGF10 Acts as a Major Ligand for FGF Receptor 2 IIIb in Mouse Multi-Organ DevelopmentBiochemical and Biophysical Research Communications, 2000